Alkem Laboratories rose 1.08% to Rs 1,868.50 after the company said that inspection of manufacturing facility at St. Louis, USA has been closed by the US FDA.
The announcement was made after market hours yesterday, 11 September 2019.Meanwhile, the S&P BSE Sensex was up 140 points or 0.38% to 37410.75.
On the BSE, 444 shares were traded in the counter so far compared with average daily volumes of 12,000 shares in the past two weeks. The stock hit a high of Rs 1,868.50 and a low of Rs 1,830.95 so far during the day.
The stock hit a 52-week high of Rs 2,265 on 10 September 2018. The stock hit a 52-week low of Rs 1,660.35 on 28 June 2019.
The large cap company has equity capital of Rs 23.91 crore. Face value per share is Rs 2.
Also Read
Alkem Laboratories said that US FDA has issued an Establishment Inspection Report (EIR) for the company's manufacturing facility located at St. Louis, Fenton Logistics Park, USA which was inspected from 16 August 2019 to 22 August 2019 and where the company received a Form 483 issued by the US FDA containing four observations. The inspection has now been closed by the US FDA.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
